BrainsWay Stimulator Receives FDA Clearance for Depression…

BrainsWay Stimulator Receives FDA Clearance for Depression…

Facebook
Twitter
LinkedIn

  • ThatThe FDA has granted 510(k) clearancetoBrainsWay Ltd(NASDAQ: BWAY) H7 deep transcranial magnetic stimulation (TMS) coil for use in the treatment of adults suffering from major depressive disorder and depression, including those with co-morbid anxiety symptoms commonly known as anxious depression.
  • The FDA’s approval was based on their review of…

Full story available at Benzinga.com

[ad_2]

Source story

More to explorer